Drug Shortage Report for POTASSIUM CHLORIDE INJECTION
Report ID | 218224 |
Drug Identification Number | 02241677 |
Brand name | POTASSIUM CHLORIDE INJECTION |
Common or Proper name | 20 mmol Potassium Chloride in 100 mL Sterile Water for Injection |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM CHLORIDE |
Strength(s) | 20mEq |
Dosage form(s) | SOLUTION LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100 mL (JB0827P) |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-01-26 |
Actual start date | 2024-01-26 |
Estimated end date | 2024-02-14 |
Actual end date | 2024-02-14 |
Shortage status | Resolved |
Updated date | 2024-02-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-02-15 | English | Compare |
v4 | 2024-02-14 | French | Compare |
v3 | 2024-02-14 | English | Compare |
v2 | 2024-02-02 | French | Compare |
v1 | 2024-02-02 | English | Compare |
Showing 1 to 5 of 5